Dashboard
Manage Tickers

AQST


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

aquestive-therapeutics-reiterates-expected-timing-for-anaphylm-nda-filing-for-q1-2025
Aquestive Therapeutics Reiterates Expected...
08/14/2024 12:08:30

hc-wainwright--co-reiterates-buy-on-aquestive-therapeutics-maintains-9-price-target
HC Wainwright & Co. Reiterates Buy on Aque...
08/14/2024 10:54:09

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Aquestive Therapeutics (NASDAQ:AQST) with a Buy and maintains ...

jmp-securities-reiterates-market-outperform-on-aquestive-therapeutics-maintains-9-price-target
JMP Securities Reiterates Market Outperfor...
08/12/2024 14:06:27

JMP Securities analyst Jason Butler reiterates Aquestive Therapeutics (NASDAQ:AQST) with a Market Outperform and maintains $...

aquestive-therapeutics-sees-fy24-revenue-57m-60m-vs-49792m-est
Aquestive Therapeutics Sees FY24 Revenue $...
08/06/2024 21:59:55

aquestive-therapeutics-q2-2024-gaap-eps-003-beats-011-estimate-sales-20099m-beat-12380m-estimate
Aquestive Therapeutics Q2 2024 GAAP EPS $(...
08/06/2024 21:30:35

Aquestive Therapeutics (NASDAQ:AQST) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate o...

hc-wainwright--co-reiterates-buy-on-aquestive-therapeutics-maintains-9-price-target
HC Wainwright & Co. Reiterates Buy on Aque...
07/26/2024 11:06:39

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Aquestive Therapeutics (NASDAQ:AQST) with a Buy and maintains ...

aquestive-therapeutics-releases-topline-pk-data-from-self-administration-study-of-anaphylm-meets-primary-endpoints-with-comparable-pk-whether-administered-by-subjects-or-hcps-final-oas-challenge-study-enrolling-pre-nda-meeting-anticipated-by-end-of-q3-2024
Aquestive Therapeutics Releases Topline PK...
07/25/2024 12:05:16

Meets primary study endpoints with pharmacokinetics (PK) comparable whether Anaphylm is administered by subjects or by healthca...

jmp-securities-reiterates-market-outperform-on-aquestive-therapeutics-maintains-9-price-target
JMP Securities Reiterates Market Outperfor...
06/26/2024 16:03:57

JMP Securities analyst Jason Butler reiterates Aquestive Therapeutics (NASDAQ:AQST) with a Market Outperform and maintains $...

oral-allergy-medication-for-emergencies---aquestive-therapeutics-investigational-therapy-works-even-with-exposure-to-liquids-of-different-temperatures-data-shows
Oral Allergy Medication For Emergencies - ...
06/25/2024 17:00:29

Aquestive Therapeutics released topline pharmacokinetic data for Anaphylm (epinephrine) Sublingual Film for severe allergic rea...

aquestive-therapeutics-reports-topline-data-from-temperature--ph-study-of-anaphylm-sublingual-film
Aquestive Therapeutics Reports Topline Dat...
06/25/2024 12:05:36

Anaphylm pharmacokinetic results unaffected by oral cavity exposure to liquids of different temperatures and pHRemains on track...

aquestive-therapeutics-to-join-russell-3000-and-russell-2000-indexes-effective-june-28-2024
Aquestive Therapeutics To Join Russell 300...
06/18/2024 12:15:27

hc-wainwright--co-reiterates-buy-on-aquestive-therapeutics-maintains-9-price-target
HC Wainwright & Co. Reiterates Buy on Aque...
06/05/2024 11:17:02

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Aquestive Therapeutics (NASDAQ:AQST) with a Buy and maintains ...

aquestive-therapeutics-appoints-cassie-jung-as-coo
Aquestive Therapeutics Appoints Cassie Jun...
06/03/2024 12:28:17

aquestive-therapeutics-announces-two-encore-poster-presentations-highlighting-positive-pk-and-pd-data-from-clinical-studies-for-anaphylm-epinephrine-sublingual-film-at-the-eastern-allergy-conference-from-may-30-to-june-2
Aquestive Therapeutics Announces Two Encor...
05/28/2024 12:31:38

leerink-partners-initiates-coverage-on-aquestive-therapeutics-with-outperform-rating-announces-price-target-of-8
Leerink Partners Initiates Coverage On Aqu...
05/10/2024 19:00:19

Leerink Partners analyst Roanna Ruiz initiates coverage on Aquestive Therapeutics (NASDAQ:AQST) with a Outperform rating and...

hc-wainwright--co-reiterates-buy-on-aquestive-therapeutics-maintains-9-price-target
HC Wainwright & Co. Reiterates Buy on Aque...
05/09/2024 11:21:50

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Aquestive Therapeutics (NASDAQ:AQST) with a Buy and maintains ...

aquestive-therapeutics-continues-to-expect-fy24-total-revenue-of-48m-51m-est-50214m
Aquestive Therapeutics Continues To Expect...
05/07/2024 22:02:25

Cash and cash equivalents were $95.2 million as of March 31, 2024. Extended cash runway into 2026 with completion of $77.5 mill...

aquestive-therapeutics-q1-2024-gaap-eps-017-misses-007-estimate-sales-12053m-miss-12262m-estimate
Aquestive Therapeutics Q1 2024 GAAP EPS $(...
05/07/2024 21:48:56

Aquestive Therapeutics (NASDAQ:AQST) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate...

hc-wainwright--co-reiterates-buy-on-aquestive-therapeutics-maintains-9-price-target
HC Wainwright & Co. Reiterates Buy on Aque...
04/30/2024 10:31:46

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Aquestive Therapeutics (NASDAQ:AQST) with a Buy and maintains ...

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
04/29/2024 16:31:20

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION